Skip to content

Clinical trials

Phase 2 Nasopharyngeal Carcinoma trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nasopharyngeal Carcinoma Phase: Phase 2 Country / region: Singapore Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20111
20152
20161
20171
20181
20201
20231
20243
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting3
Suspended1
Terminated1
Unknown status1
Active, not recruiting1
Withdrawn1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National University Hospital, Singapore4
National Cancer Centre, Singapore3
National Cancer Institute (NCI)2
Celgene1
Johns Hopkins University1
Novartis Pharmaceuticals1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1
Sue Yom1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nasopharyngeal Carcinoma14
Nasopharyngeal Neoplasms5
Neoplasm Metastasis2
Recurrence2
Disorders of Sex Development1
Epstein-Barr Virus Infections1
Head and Neck Neoplasms1
Neoplasms1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.